Showing results (111-120 of 125) with videos related to
Sort By:
Pageof 13
Frontiers in Oncology|May 10, 2021
SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast CancerTomás Pascual, Mafalda Oliveira, Eva Ciruelos, et al.Cancers|September 23, 2022
Primary Chemoradiotherapy Treatment (PCRT) for HER2+ and Triple Negative Breast Cancer Patients: A Feasible CombinationRaquel Ciérvide, Ángel Montero, Eduardo García-Rico, et al.European Journal of Cancer (Oxford, England : 1990)|August 23, 2021
Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive metastatic breast cancer: Patient-reported outcomes in the PEARL studyZsuzsanna Kahan, Miguel Gil-Gil, Manuel Ruiz-Borrego, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2025
Associations of the HER2DX Genomic Test with Biological and Pathological Features in HER2-positive Breast CancerEsther Sanfeliu, Anabel Martínez-Romero, Mercedes Marín-Aguilera, et al.Eclinicalmedicine|April 19, 2024
Preventing alpelisib-related hyperglycaemia in HR+/HER2-/<i>PIK3CA</i>-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trialAntonio Llombart-Cussac, José Manuel Pérez-Garcia, Manuel Ruiz Borrego, et al.Nature Communications|March 1, 2023
Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancerAleix Prat, Fara Brasó-Maristany, Olga Martínez-Sáez, et al.NPJ Breast Cancer|April 25, 2025
HER2DX ERBB2 mRNA score in first-line advanced HER2-positive breast cancer treated with chemotherapy, trastuzumab, and pertuzumabRodrigo Sánchez-Bayona, Olga Martínez-Sáez, Denys Romero-Romero, et al.The New England Journal of Medicine|December 16, 2014
Adjuvant ovarian suppression in premenopausal breast cancerPrudence A Francis, Meredith M Regan, Gini F Fleming, et al.Frontiers in Oncology|May 15, 2023
HOPE (SOLTI-1903) breast cancer study: real-world, patient-centric, clinical practice study to assess the impact of genomic data on next treatment decision-choice in patients with locally advanced or metastatic breast cancerRubén Olivera-Salguero, Elia Seguí, Juan Miguel Cejalvo, et al.Current Cancer Drug Targets|August 18, 2015
Nab-Paclitaxel in Metastatic Breast Cancer: Defining the Best Patient ProfileAntonio González-Martín, Emilio Alba, Eva Ciruelos, et al.Pageof 13